Part 1: Guidelines and Recommendations for Treating nmCRPC
During a live virtual event, Eleni Efstathiou, MD, PhD, discussed the recommended approach to front-line treatment of castration-resistant prostate cancer.
Related Articles
Treatment Considerations for Fit Elderly BPDCN Patients
Dr. Schiller will discuss how their treatment approach would differ for a 74-year-old BPDCN patient with only well-controlled type 2 diabetes as a comorbidity and…
Subgroup Analyses of COMMANDS Trial Favor Luspatercept in MDS
Amer Zeidan, MBBS, discusses the primary end point and subgroup analyses performed on the COMMANDS trial of luspatercept-amt for treating anemia in patients with myelodysplastic…
April Roundtable Roundup: B-cell Lymphoma
In separate, live virtual events, Kami J. Maddocks, MD, and Sairah Ahmed, MD, discussed the use of loncastuximab tesirine for a patient with later-line diffuse…
FDA Grants Accelerated Approval to Tovorafenib in Pediatric Low-Grade Glioma
The FDA has approved the new drug application of tovorafenib for the treatment of pediatric low-grade glioma.
Patient Case: Pathology of Graft Versus Host Disease
Yi-Bin Chen, MD, presents a patient case, detailing the symptomology and pathology of graft versus host disease, such as dry eyes, dry mouth, and difficulty…
Combating Resistance Mechanisms to Treatment in Thyroid Cancer
Lova Sun, MD, MSCE, discusses resistance mechanisms against targeted agents for the treatment of thyroid cancer.
FDA Grants Accelerated Approval to Tovorafenib in Pediatric Low-Grade Glioma
The FDA has approved the new drug application of tovorafenib for the treatment of pediatric low-grade glioma.
FDA Approves 177Lu-Dotatate in Patients 12 and Up for GEP-NETs
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
FDA Approves 177Lu-Dotatate in Patients 12 and Up for GEP-NETs
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
Powell Reviews Updated IO/TKI Data and AE Management in Endometrial Cancer
During a Case-Based Roundtable® event, Matthew A. Powell, MD, discussed the case of a patient with advanced endometrial cancer treated with lenvatinib plus pembrolizumab who experienced…